Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes.
Flores-Umanzor EJ, Cepas-Guillen PL, Vázquez S, Fernandez-Valledor A, Ivey-Miranda J, Izquierdo M, Caldentey G, Jimenez-Britez G, Regueiro A, Freixa X, Farrero M, Ferreira-González I, Martin-Yuste V, Sabaté M.
Flores-Umanzor EJ, et al. Among authors: jimenez britez g.
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):376-383. doi: 10.1002/ccd.28815. Epub 2020 Feb 25.
Catheter Cardiovasc Interv. 2021.
PMID: 32096926